 | • レポートコード：GIR-107A12659 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腎バイオマーカーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腎バイオマーカーの種類別市場規模（機能性バイオマーカー、アップレギュレーションタンパク質、その他）、用途別市場規模（病院、診断研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腎バイオマーカーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Beckman Coulter (Danaher)、Thermo Fisher Scientific、Abbott Laboratories、BioPorto Diagnostics、Astute Medical、Randox Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：機能性バイオマーカー、アップレギュレーションタンパク質、その他 ・用途別分析2016年-2026年：病院、診断研究所、その他 ・腎バイオマーカーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腎バイオマーカーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腎バイオマーカーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腎バイオマーカーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腎バイオマーカーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Renal Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Renal Biomarker size is estimated to be USD 1151.9 million in 2026 from USD 992.3 million in 2020, with a change XX% between 2020 and 2021. The global Renal Biomarker market size is expected to grow at a CAGR of 3.8% for the next five years.
Market segmentation
Renal Biomarker market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Functional Biomarker
Up-Regulated Proteins
Others
Market segment by Application, can be divided into
Hospitals
Diagnostic Labs
Others
Market segment by players, this report covers
Beckman Coulter (Danaher)
Thermo Fisher Scientific
Abbott Laboratories
BioPorto Diagnostics
Astute Medical
Randox Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Renal Biomarker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Renal Biomarker, with revenue, gross margin and global market share of Renal Biomarker from 2019 to 2021.
Chapter 3, the Renal Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Renal Biomarker market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Renal Biomarker research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Renal Biomarker
1.2 Classification of Renal Biomarker by Type
1.2.1 Overview: Global Renal Biomarker Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Renal Biomarker Revenue Market Share by Type in 2020
1.2.3 Functional Biomarker
1.2.4 Up-Regulated Proteins
1.2.5 Others
1.3 Global Renal Biomarker Market by Application
1.3.1 Overview: Global Renal Biomarker Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Diagnostic Labs
1.3.4 Others
1.4 Global Renal Biomarker Market Size & Forecast
1.5 Global Renal Biomarker Market Size and Forecast by Region
1.5.1 Global Renal Biomarker Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Renal Biomarker Market Size by Region, (2016-2021)
1.5.3 North America Renal Biomarker Market Size and Prospect (2016-2026)
1.5.4 Europe Renal Biomarker Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Renal Biomarker Market Size and Prospect (2016-2026)
1.5.6 South America Renal Biomarker Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Renal Biomarker Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Renal Biomarker Market Drivers
1.6.2 Renal Biomarker Market Restraints
1.6.3 Renal Biomarker Trends Analysis
2 Company Profiles
2.1 Beckman Coulter (Danaher)
2.1.1 Beckman Coulter (Danaher) Details
2.1.2 Beckman Coulter (Danaher) Major Business
2.1.3 Beckman Coulter (Danaher) Renal Biomarker Product and Solutions
2.1.4 Beckman Coulter (Danaher) Renal Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Beckman Coulter (Danaher) Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Renal Biomarker Product and Solutions
2.2.4 Thermo Fisher Scientific Renal Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Renal Biomarker Product and Solutions
2.3.4 Abbott Laboratories Renal Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 BioPorto Diagnostics
2.4.1 BioPorto Diagnostics Details
2.4.2 BioPorto Diagnostics Major Business
2.4.3 BioPorto Diagnostics Renal Biomarker Product and Solutions
2.4.4 BioPorto Diagnostics Renal Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BioPorto Diagnostics Recent Developments and Future Plans
2.5 Astute Medical
2.5.1 Astute Medical Details
2.5.2 Astute Medical Major Business
2.5.3 Astute Medical Renal Biomarker Product and Solutions
2.5.4 Astute Medical Renal Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Astute Medical Recent Developments and Future Plans
2.6 Randox Laboratories
2.6.1 Randox Laboratories Details
2.6.2 Randox Laboratories Major Business
2.6.3 Randox Laboratories Renal Biomarker Product and Solutions
2.6.4 Randox Laboratories Renal Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Randox Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Renal Biomarker Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Renal Biomarker Players Market Share
3.2.2 Top 10 Renal Biomarker Players Market Share
3.2.3 Market Competition Trend
3.3 Renal Biomarker Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Renal Biomarker Revenue and Market Share by Type (2016-2021)
4.2 Global Renal Biomarker Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Renal Biomarker Revenue Market Share by Application (2016-2021)
5.2 Renal Biomarker Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Renal Biomarker Revenue by Type (2016-2026)
6.2 North America Renal Biomarker Revenue by Application (2016-2026)
6.3 North America Renal Biomarker Market Size by Country
6.3.1 North America Renal Biomarker Revenue by Country (2016-2026)
6.3.2 United States Renal Biomarker Market Size and Forecast (2016-2026)
6.3.3 Canada Renal Biomarker Market Size and Forecast (2016-2026)
6.3.4 Mexico Renal Biomarker Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Renal Biomarker Revenue by Type (2016-2026)
7.2 Europe Renal Biomarker Revenue by Application (2016-2026)
7.3 Europe Renal Biomarker Market Size by Country
7.3.1 Europe Renal Biomarker Revenue by Country (2016-2026)
7.3.2 Germany Renal Biomarker Market Size and Forecast (2016-2026)
7.3.3 France Renal Biomarker Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Renal Biomarker Market Size and Forecast (2016-2026)
7.3.5 Russia Renal Biomarker Market Size and Forecast (2016-2026)
7.3.6 Italy Renal Biomarker Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Renal Biomarker Revenue by Type (2016-2026)
8.2 Asia-Pacific Renal Biomarker Revenue by Application (2016-2026)
8.3 Asia-Pacific Renal Biomarker Market Size by Region
8.3.1 Asia-Pacific Renal Biomarker Revenue by Region (2016-2026)
8.3.2 China Renal Biomarker Market Size and Forecast (2016-2026)
8.3.3 Japan Renal Biomarker Market Size and Forecast (2016-2026)
8.3.4 South Korea Renal Biomarker Market Size and Forecast (2016-2026)
8.3.5 India Renal Biomarker Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Renal Biomarker Market Size and Forecast (2016-2026)
8.3.7 Australia Renal Biomarker Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Renal Biomarker Revenue by Type (2016-2026)
9.2 South America Renal Biomarker Revenue by Application (2016-2026)
9.3 South America Renal Biomarker Market Size by Country
9.3.1 South America Renal Biomarker Revenue by Country (2016-2026)
9.3.2 Brazil Renal Biomarker Market Size and Forecast (2016-2026)
9.3.3 Argentina Renal Biomarker Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Renal Biomarker Revenue by Type (2016-2026)
10.2 Middle East & Africa Renal Biomarker Revenue by Application (2016-2026)
10.3 Middle East & Africa Renal Biomarker Market Size by Country
10.3.1 Middle East & Africa Renal Biomarker Revenue by Country (2016-2026)
10.3.2 Turkey Renal Biomarker Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Renal Biomarker Market Size and Forecast (2016-2026)
10.3.4 UAE Renal Biomarker Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Renal Biomarker Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Renal Biomarker Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Renal Biomarker Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Renal Biomarker Revenue (USD Million) by Region (2016-2021)
Table 5. Global Renal Biomarker Revenue Market Share by Region (2021-2026)
Table 6. Beckman Coulter (Danaher) Corporate Information, Head Office, and Major Competitors
Table 7. Beckman Coulter (Danaher) Major Business
Table 8. Beckman Coulter (Danaher) Renal Biomarker Product and Solutions
Table 9. Beckman Coulter (Danaher) Renal Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Renal Biomarker Product and Solutions
Table 13. Thermo Fisher Scientific Renal Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Renal Biomarker Product and Solutions
Table 17. Abbott Laboratories Renal Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BioPorto Diagnostics Corporate Information, Head Office, and Major Competitors
Table 19. BioPorto Diagnostics Major Business
Table 20. BioPorto Diagnostics Renal Biomarker Product and Solutions
Table 21. BioPorto Diagnostics Renal Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Astute Medical Corporate Information, Head Office, and Major Competitors
Table 23. Astute Medical Major Business
Table 24. Astute Medical Renal Biomarker Product and Solutions
Table 25. Astute Medical Renal Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Randox Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Randox Laboratories Major Business
Table 28. Randox Laboratories Renal Biomarker Product and Solutions
Table 29. Randox Laboratories Renal Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Renal Biomarker Revenue (USD Million) by Players (2019-2021)
Table 31. Global Renal Biomarker Revenue Share by Players (2019-2021)
Table 32. Breakdown of Renal Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Renal Biomarker Players Head Office, Products and Services Provided
Table 34. Renal Biomarker Mergers & Acquisitions in the Past Five Years
Table 35. Renal Biomarker New Entrants and Expansion Plans
Table 36. Global Renal Biomarker Revenue (USD Million) by Type (2016-2021)
Table 37. Global Renal Biomarker Revenue Share by Type (2016-2021)
Table 38. Global Renal Biomarker Revenue Forecast by Type (2021-2026)
Table 39. Global Renal Biomarker Revenue by Application (2016-2021)
Table 40. Global Renal Biomarker Revenue Forecast by Application (2021-2026)
Table 41. North America Renal Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Renal Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Renal Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Renal Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Renal Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Renal Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Renal Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Renal Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Renal Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Renal Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Renal Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Renal Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Renal Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Renal Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Renal Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Renal Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Renal Biomarker Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Renal Biomarker Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Renal Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Renal Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Renal Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Renal Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Renal Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Renal Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Renal Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Renal Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Renal Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Renal Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Renal Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Renal Biomarker Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Renal Biomarker Picture
Figure 2. Global Renal Biomarker Revenue Market Share by Type in 2020
Figure 3. Functional Biomarker
Figure 4. Up-Regulated Proteins
Figure 5. Others
Figure 6. Renal Biomarker Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Diagnostic Labs Picture
Figure 9. Others Picture
Figure 10. Global Renal Biomarker Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Renal Biomarker Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Renal Biomarker Revenue Market Share by Region (2016-2026)
Figure 13. Global Renal Biomarker Revenue Market Share by Region in 2020
Figure 14. North America Renal Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Renal Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Renal Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Renal Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Renal Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Renal Biomarker Market Drivers
Figure 20. Renal Biomarker Market Restraints
Figure 21. Renal Biomarker Market Trends
Figure 22. Beckman Coulter (Danaher) Recent Developments and Future Plans
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. BioPorto Diagnostics Recent Developments and Future Plans
Figure 26. Astute Medical Recent Developments and Future Plans
Figure 27. Randox Laboratories Recent Developments and Future Plans
Figure 28. Global Renal Biomarker Revenue Share by Players in 2020
Figure 29. Renal Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Renal Biomarker Revenue Market Share in 2020
Figure 31. Global Top 10 Players Renal Biomarker Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Renal Biomarker Revenue Share by Type in 2020
Figure 34. Global Renal Biomarker Market Share Forecast by Type (2021-2026)
Figure 35. Global Renal Biomarker Revenue Share by Application in 2020
Figure 36. Global Renal Biomarker Market Share Forecast by Application (2021-2026)
Figure 37. North America Renal Biomarker Sales Market Share by Type (2016-2026)
Figure 38. North America Renal Biomarker Sales Market Share by Application (2016-2026)
Figure 39. North America Renal Biomarker Revenue Market Share by Country (2016-2026)
Figure 40. United States Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Renal Biomarker Sales Market Share by Type (2016-2026)
Figure 44. Europe Renal Biomarker Sales Market Share by Application (2016-2026)
Figure 45. Europe Renal Biomarker Revenue Market Share by Country (2016-2026)
Figure 46. Germany Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Renal Biomarker Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Renal Biomarker Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Renal Biomarker Revenue Market Share by Region (2016-2026)
Figure 54. China Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Renal Biomarker Sales Market Share by Type (2016-2026)
Figure 61. South America Renal Biomarker Sales Market Share by Application (2016-2026)
Figure 62. South America Renal Biomarker Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Renal Biomarker Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Renal Biomarker Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Renal Biomarker Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Renal Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界のマルチプレックスバイオマーカーイメージング市場 2021：企業別、地域別、種類・用途別 The Multiplex Biomarker Imaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 腫瘍学バイオマーカーの世界市場 2019年版：種類別（肺がん、乳がん、大腸がん、前立腺がん、胃がん、その他）、用途別（診断、創薬＆開発、予後、リスクアセスメント、その他） Scope of the Report: The global Oncology Biomarker market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also f…
- 腫瘍バイオマーカー試験市場：世界及び中国市場分析・予測（～2024年） Tumor Biomarker Test Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Tumor Biomarker Test industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tumor Biomarker Test manufac…
- 世界の持続的腎代替療法市場 2021：企業別、地域別、種類・用途別 The Continuous Renal Replacement Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の腎疾患治療市場 2021：企業別、地域別、種類・用途別 The Renal Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…